Cullinan Oncology Llc Stock Technical Analysis
CGEM Stock | USD 8.09 0.21 2.53% |
As of the 27th of March, Cullinan Oncology shows the Risk Adjusted Performance of (0.09), mean deviation of 2.52, and Standard Deviation of 3.22. Cullinan Oncology LLC technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cullinan Oncology LLC standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and kurtosis to decide if Cullinan Oncology LLC is priced correctly, providing market reflects its regular price of 8.09 per share. Given that Cullinan Oncology has information ratio of (0.12), we suggest you to validate Cullinan Oncology LLC's prevailing market performance to make sure the company can sustain itself at a future point.
Cullinan Oncology Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cullinan, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CullinanCullinan |
Cullinan Oncology Analyst Consensus
Target Price | Advice | # of Analysts | |
33.0 | Strong Buy | 10 | Odds |
Most Cullinan analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cullinan stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cullinan Oncology LLC, talking to its executives and customers, or listening to Cullinan conference calls.
Cullinan Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Cullinan Oncology LLC Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Cullinan Oncology LLC volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Cullinan Oncology LLC Trend Analysis
Use this graph to draw trend lines for Cullinan Oncology LLC. You can use it to identify possible trend reversals for Cullinan Oncology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Cullinan Oncology price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Cullinan Oncology Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Cullinan Oncology LLC applied against its price change over selected period. The best fit line has a slop of 0.07 , which may suggest that Cullinan Oncology LLC market price will keep on failing further. It has 122 observation points and a regression sum of squares at 167.66, which is the sum of squared deviations for the predicted Cullinan Oncology price change compared to its average price change.About Cullinan Oncology Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cullinan Oncology LLC on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cullinan Oncology LLC based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cullinan Oncology LLC price pattern first instead of the macroeconomic environment surrounding Cullinan Oncology LLC. By analyzing Cullinan Oncology's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cullinan Oncology's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cullinan Oncology specific price patterns or momentum indicators. Please read more on our technical analysis page.
2010 | 2024 (projected) | Interest Debt Per Share | 0.11 | 0.0995 | Revenue Per Share | 0.43 | 0.38 |
Cullinan Oncology March 27, 2025 Technical Indicators
Most technical analysis of Cullinan help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cullinan from various momentum indicators to cycle indicators. When you analyze Cullinan charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.09) | |||
Market Risk Adjusted Performance | (0.64) | |||
Mean Deviation | 2.52 | |||
Coefficient Of Variation | (846.52) | |||
Standard Deviation | 3.22 | |||
Variance | 10.4 | |||
Information Ratio | (0.12) | |||
Jensen Alpha | (0.39) | |||
Total Risk Alpha | (0.38) | |||
Treynor Ratio | (0.65) | |||
Maximum Drawdown | 15.27 | |||
Value At Risk | (6.43) | |||
Potential Upside | 5.13 | |||
Skewness | (0.15) | |||
Kurtosis | 0.5683 |
Cullinan Oncology March 27, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Cullinan stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 25,081 | ||
Daily Balance Of Power | (0.44) | ||
Rate Of Daily Change | 0.97 | ||
Day Median Price | 8.25 | ||
Day Typical Price | 8.20 | ||
Price Action Indicator | (0.27) |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cullinan Oncology LLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cullinan Oncology. If investors know Cullinan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cullinan Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cullinan Oncology LLC is measured differently than its book value, which is the value of Cullinan that is recorded on the company's balance sheet. Investors also form their own opinion of Cullinan Oncology's value that differs from its market value or its book value, called intrinsic value, which is Cullinan Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cullinan Oncology's market value can be influenced by many factors that don't directly affect Cullinan Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cullinan Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cullinan Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cullinan Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.